BayMark Health Services of Ohio Inc - Milford Ohio

BayMark Health Services of Ohio Inc - Milford, OH

Baymark Health Services Of Ohio Inc is treatment facility located at 749 C State Route 28 in the 45150 zip code in Milford, OH that offers medication-assisted substance abuse treatment. It accepts pregnant/postpartum women into its treatment program. Baymark Health Services Of Ohio Inc provides methadone maintenance, methadone detox and buprenorphine detox to young adults and adults. Some of the treatment approaches used by Baymark Health Services Of Ohio Inc consist of community reinforcement plus vouchers, trauma-related counseling and cognitive behavioral therapy. Baymark Health Services Of Ohio Inc also offers detoxification programs and offers opioid detox.

Address: 749 C State Route 28, Milford, OH 45150

1. Types of Care
2. Service Settings
3. Opioid Medications used in Treatment
4. Type of Alcohol Use Disorder Treatment
5. Type Of Treatment
6. Pharmacotherapies
7. Treatment Approaches
8. FacilityOwnership
9. License/Certification/Accreditation
10. Payment/Insurance/Funding Accepted
11. Special Programs/ Population Groups Supported
12. Assessment/Pre-treatment
13. Screening & Testing
14. Transitional Services
15. Ancillary Services
16. Detoxification
17. Counseling Services and Education
18. Tobacco/Screening Services
19. Facility Smoking Policy
20. Age Groups Accepted
21. Gender Accepted
22. Exclusive Services

Here are the full facility listing details on BayMark Health Services of Ohio Inc in Milford, OH:

Phone #: 513-214-2094

Is Methadone a safe option for addiction treatment?

Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at BayMark Health Services of Ohio Inc. Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.

Here are some key points to consider regarding the safety of methadone treatment:

1. Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.

2. Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.

3. Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).

4. Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.

5. Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.

However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.

Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like BayMark Health Services of Ohio Inc to conduct a thorough assessment before starting someone on methadone.